Butylamine → 5,6-Dimethyl-2-butylamino-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride

HRID 275917노트

반응식

HRID 275917 반응식
[CH2:1]([NH2:5])[CH2:2][CH2:3][CH3:4].C(N(CC)CC)C.[Cl:13][C:14]1[N:19]=[C:18]([N:20]2[CH2:29][CH2:28][C:27]3[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=3)[CH:21]2[CH3:30])[C:17]([CH3:31])=[C:16]([CH3:32])[N:15]=1>CN(C)C=O>[ClH:13].[CH3:31][C:17]1[C:18]([N:20]2[CH2:29][CH2:28][C:27]3[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=3)[CH:21]2[CH3:30])=[N:19][C:14]([NH:5][CH2:1][CH2:2][CH2:3][CH3:4])=[N:15][C:16]=1[CH3:32]

참가 물질

5

반응물 3

HCID 8007ButylamineHCID 8471TriethylamineHCID 111853185,6-Dimethyl-2-chloro4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine

생성물 1

HCID 183157795,6-Dimethyl-2-butylamino-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride수율 68.5%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

After butylamine(0.52 ml, 5.22 mmol) and triethylamine(0.36 ml, 2.59 mmol) were added to a solution of 2-chloro-5,6-dimethyl-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine(0.5 g, 1.74 mmol) in dimethylformamide, 430 mg of the titled compound was obtained in accordance with the same procedure as in Example 1.

출처 및 근거

ORD 기록
ord-16c6984911b541e6b2f73188a0b03fa8
출처 데이터셋
uspto-grants-2002_03
특허 번호
US06352993B1

반응 노트

불러오는 중…